© Getty Images
Will mass injections against COVID-19 encourage the mutation of more dangerous versions of SARS-CoV-2? In the video above, WhatsHerFace questions why the U.K. government is procuring 6 million pounds' worth of body bags, or "temporary body storage," even as government officials announce that the current vaccination rate has "created a protective wall" against the infection.
1
If that's true, why are they expecting an "excess death scenario" requiring massive numbers of body bags? The procurement agreement will remain in effect for a period of four years. Does the U.K. government know something they're not sharing with the public?
Have they peeked at the actual science and realized that mass vaccination during an active pandemic might encourage mutations that evade vaccine-induced defenses, or that the gene-modifying injections might render the vaccinated more susceptible to serious illness and death through a mechanism known as antibody-dependent enhancement (ADE) or the more descriptive term, paradoxical immune enhancement (PIE)?
Comment: This is one possibility, but as Dr. Gaby pointed out in her
article, it's the recombination of different viral sequences that could produce superbugs rather than variants of the same.
Back in February 2020, long before lockdowns were rolled out in the Western world, someone made the connection of how components of the SARS-CoV-2 spike protein (glycoprotein S) are homologous to some of our human endogenous retroviruses - the viruses that are found in our DNA. Pfizer's mRNA vaccine is designed to produce the SARS-CoV-2 spike protein in the human body.
Various researchers have brought to our attention the concept of viral recombination: when two viruses meet, they are very effective at exchanging genetic material between each other and a new recombined virus can be generated from this exchange. Due to the properties of our own DNA, we might not just be looking here at the arrival of a new recombined flu-like virus (the coronavirus of the vaccine + a flu virus in our cells), but - in the worst case scenario - to the recombining of a virus that is far more deadly.
Comment: It was recently discovered that Ebola can remain in the system and cause an antibody spike 6 months after the initial infection, possibly causing the carrier to become infectious again.
See also: